Changxue Lu

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 9

Top Topics

Acute Myeloid Leukemia

Loop Mediated Isothermal Amplification

Circulating Tumor

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

JCO precision oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Catherine Handy Marshall, Lukasz P Gondek, Violet Daniels, Changxue Lu, Sergiu Pasca, Jiajun Xie, Mark C Markowski, Channing J Paller, Laura A Sena, Samuel R Denmeade, Jun Luo, Emmanuel S Antonarakis
Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer. The Prostate 84 (10) (2024)
Susan Halabi, Siyuan Guo, Joseph J Park, David M Nanus, Daniel J George, Emmanuel S Antonarakis, Daniel Costin Danila, Russell Zelig Szmulewitz, Donald P McDonnell, John D Norris, Changxue Lu, Jun Luo, Andrew J Armstrong
The Impact of Circulating Tumor Cell HOXB13 RNA Detection in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (6) (2024)
Catherine Handy Marshall, Lukasz P Gondek, Violet Daniels, Changxue Lu, Sergiu Pasca, Jiajun Xie, Mark C Markowski, Channing J Paller, Laura A Sena, Samuel R Denmeade, Jun Luo, Emmanuel S Antonarakis
Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer. The Prostate 84 (10) (2024)
Susan Halabi, Siyuan Guo, Joseph J Park, David M Nanus, Daniel J George, Emmanuel S Antonarakis, Daniel Costin Danila, Russell Zelig Szmulewitz, Donald P McDonnell, John D Norris, Changxue Lu, Jun Luo, Andrew J Armstrong
The Impact of Circulating Tumor Cell HOXB13 RNA Detection in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (6) (2024)
Susan Halabi, Siyuan Guo, Joseph J Park, David M Nanus, Daniel J George, Emmanuel S Antonarakis, Daniel Costin Danila, Russell Zelig Szmulewitz, Donald P McDonnell, John D Norris, Changxue Lu, Jun Luo, Andrew J Armstrong
The Impact of Circulating Tumor Cell HOXB13 RNA Detection in Men with Metastatic Castration-Resistant Prostate Cancer (mCRPC) Treated with Abiraterone or Enzalutamide. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (6) (2024)
Susan Halabi, Siyuan Guo, Joseph J Park, David M Nanus, Daniel J George, Emmanuel S Antonarakis, Daniel Costin Danila, Russell Zelig Szmulewitz, Donald P McDonnell, John D Norris, Changxue Lu, Jun Luo, Andrew J Armstrong
The impact of circulating tumor cell HOXB13 RNA detection in men with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Catherine Handy Marshall, Lukasz P Gondek, Violet Daniels, Changxue Lu, Sergiu Pasca, Jiajun Xie, Mark C Markowski, Channing J Paller, Laura A Sena, Samuel R Denmeade, Jun Luo, Emmanuel S Antonarakis
Association of PARP inhibitor treatment on the prevalence and progression of clonal hematopoiesis in patients with advanced prostate cancer. The Prostate (2024)
Mayuko Kanayama, Changxue Lu, Jun Luo, Emmanuel S Antonarakis
AR Splicing Variants and Resistance to AR Targeting Agents. Cancers 13 (11) (2021)
Andrew J Armstrong, Jun Luo, David M Nanus, Paraskevi Giannakakou, Russell Z Szmulewitz, Daniel Costin Danila, Patrick Healy, Monika Anand, William R Berry, Tian Zhang, Michael R Harrison, Changxue Lu, Yan Chen, Giuseppe Galletti, Joseph D Schonhoft, Howard I Scher, Richard Wenstrup, Scott T Tagawa, Emmanuel S Antonarakis, Daniel J George, Susan Halabi
Prospective Multicenter Study of Circulating Tumor Cell AR-V7 and Taxane Versus Hormonal Treatment Outcomes in Metastatic Castration-Resistant Prostate Cancer. JCO precision oncology 4 (2020)